Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIfT: LIQ001 Adjuvant with Fluzone Vaccine
NCT01224262Phase 2Completed
- Sponsor
- Liquidia Corporation
- Start
- Sep 2010
- Primary completion
- Dec 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of LIQ001 in influenza, sponsored by Liquidia Corporation. Started Sep 2010; status: completed.
02
Drugs
LIQ001
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01224262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224262.